News & Publications for:

Richard Perrin

Cerebrospinal fluid biomarkers for clinical trials: why markers for differential diagnosis are important

Posted on July 23, 2013

Richard J. Perrin, MD, PhD; Arch Neurol. 2012;69(11):1407-1408. doi:10.1001/archneurol.2012.2353. Read More

Posted in: HPAN, Publications Faculty:

Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.

Posted on July 23, 2013

Richard J. Perrin,Jacqueline E. Payton, James P. Malone, Petra Gilmore, Alan E. Davis, Chengjie Xiong, Anne M. Fagan, R. Reid Townsend, and David M. Holtzman,
Dulce Elena Casarini, Editor; PLoS One. 2013; 8(5): e64314.Published online 2013 May 20. doi: 10.1371/journal.pone.0064314
Read More

Posted in: HPAN, Publications Faculty: , ,

Plasma multi-analyte profiling in mild cognitive impairment and Alzheimer’s disease

Posted on September 18, 2012

Hu WT, Holtzman DM, Fagan AM, Shaw LM, Perrin R, Arnold SE, Grossman M, Xiong C, Craig-Schapiro R, Clark CM, Pickering E, Kuhn M, Chen Y, Van Deerlin VM, McCluskey L, Elman L, Karlawish J, Chen-Plotkin A, Hurtig HI, Siderowf A, Swenson F, Lee VM, Morris JC, Trojanowski JQ, Soares H; For the Alzheimer’s Disease Neuroimaging Initiative (2012). Neurology, 79(9): 897-905 Read More

Posted in: HPAN, Neurodegeneration, Publications Faculty: , ,

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease

Posted on September 18, 2012

Fagan AM, Perrin RJ (2012). Biomark Med, 6(4):455-76 Read More

Posted in: HPAN, Publications Faculty: ,

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer’s Disease

Posted on September 18, 2011

Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, Davis AE, Roe CM, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, Kaye JA, Morris JC, Holtzman DM, Townsend RR, Fagan AM (2011). PLoS One, 6(1):e16032 Read More

Posted in: HPAN, Publications Faculty: , , ,